CClinicalTrials.gg
CompletedNCT05870904Updated May 23, 2023

Dry Needling & Trigger Point Compression Release in Neck Pain

An interventional study of Dry Needling in Neck Pain, Trigger Point Pain, Myofascial and Neck Muscle Issue, sponsored by Health Education Research Foundation (HERF). Completed at 1 site in Pakistan. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-05-23.

Sponsored by Health Education Research Foundation (HERF) · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Jun 2021, registered Apr 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

This randomized control trial was conducted to investigate the efficacy of trigger point dry needling which is a modern treatment intervention compared with ischemic compression release in the patients having neck pain due to myofascial trigger points.

Read the detailed description

Many treatment protocols have been used in the clinical arena for the improvement of neck pain but un-availability of follow-up studies and lack of evidence of modern treatment interventions are few shortcomings a researcher faces. Thus, a need stands up to address these perspectives for newer treatment strategies. This randomized control trial is conducted to investigate the efficacy of trigger point dry needling which is a modern treatment intervention compared with ischemic compression release in the patients having neck pain due to myofascial trigger points. Findings of this research will assist in creating awareness about better treatment intervention for trigger point release among medical community.

02

Conditions studied

  • Neck Pain
  • Trigger Point Pain, Myofascial
  • Neck Muscle Issue
  • Muscle Tightness
  • Neckache

Keywords

  • Dry Needling
  • Ischemic Compression
  • Neck Pain
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 30 is below the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Health Education Research Foundation (HERF) is the lead sponsor of 15 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients between the age group of 20 to 40 years.
  • Both Male and female patients.
  • Patients presenting with neck pain due to MTrP's.
  • The presence of a palpable taut band in the neck region.
  • Patients reporting typically referred pain pattern of the MTrP in response to compression.

Exclusion criteria

Exclusion Criteria:

  • Patients with any associated comorbidities such as hypertension and diabetes.
  • Patients with known history of fibromyalgia syndrome, whiplash injury, cervical spine surgery fracture and cervical radiculopathy.
  • Patients with any systemic disease such as rheumatism and tuberculosis or cervical myelopathy and multiple sclerosis.
  • Patients with history of myofascial trigger point therapy one month prior to enrollment.
  • Patients with non-cooperative attitude, fear or any contraindications to needling.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Dry Needling Group

    Received dry needling through the insertion of fusiform needle for the trigger point release on 3 days a week aimed at pain relief.

    Other: Dry Needling

  • Active comparator
    Ischemic Compression Group

    Received ischemic compression release through thumb pressure for trigger points on 3 days a week.

    Other: Dry Needling

Interventions

  • OtherDry Needling

    Dry Needling includes the insertion of a fine, strong filiform needle without presentation of any pain relieving medicine. Ischemic pressure is usually applied to trigger point, in what is known as trigger point therapy, where enough continuous pressure is applied to a trigger point within a tolerable measure of pain, and as discomfort is decreased, extra pressure is gradually applied

    Also known as: Ischemic Compression

06

What researchers measure

Primary outcomes

  1. Change in Pain assessed through Visual Analogue Pain Scale

    To measure the change in terms of betterment or aggravation in the intensity of pain baseline then after week 1,week 2 and after week 3.

    Time frame: Data was Collected at Baseline and after week 1,2 & 3.

  2. Change in degree of disability assessed through Northwick Park Neck Pain Questionnaire.

    To measure change in the intensity of neck pain and the consequent patient disabilities at baseline then after week 1,week 2 and after week 3.

    Time frame: Data was Collected at Baseline and after week 1,2 & 3.

07

Study locations

1 site
  • Bashir Institute of Health Sciences,Bashir General & Dental Hospital
    Islamabad, 45400, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05870904
Lead sponsor
Health Education Research Foundation (HERF)
Responsible party
Mamoona Tasleem Afzal (Senior Lecturer, Health Education Research Foundation (HERF)) — Principal investigator
First posted
May 23, 2023
Start date
Jun 1, 2021
Primary completion
Sep 30, 2021
Completion
Oct 31, 2021
Last update
May 23, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion